In conclusion, we show that a the slight up-regulation of CD24 both on PCs in vitro, and validated in MM patient’s PCs, correlate to a less tumorigenic phenotype, that involves CXCR4 and CD38 co-expression. The gene discussed is CD38; the disease is Miyoshi myopathy.